(VIANEWS) – Lantheus Holdings (LNTH), Ares Capital (ARCC), Medpace Holdings (MEDP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Lantheus Holdings (LNTH)
27.4% sales growth and 6.16% return on equity
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; and RELISTOR for opioid-induced constipation. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical. It provides Thallium-201 to detect cardiovascular disease; Gallium-67 to detect various infections and cancerous tumors; and Quadramet for severe bone pain associated with osteoblastic metastatic bone lesions. The company also develops PyL for prostate cancer; flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroendocrine tumors; PSMA TTC, a thorium-227 labeled PSMA-targeted antibody therapeutic; 1404, a Tc-99m labeled small molecule; PSMA-AI, an AI-based imaging analysis technology; and leronlimab, an investigational humanized monoclonal antibody. It serves radiopharmacies, PET manufacturing facilities, integrated delivery networks, hospitals, clinics, and group practices. The company has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM Toyama Chemical Co. Ltd.; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
Earnings Per Share
As for profitability, Lantheus Holdings has a trailing twelve months EPS of $0.41.
PE Ratio
Lantheus Holdings has a trailing twelve months price to earnings ratio of 194.2. Meaning, the purchaser of the share is investing $194.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.16%.
Volume
Today’s last reported volume for Lantheus Holdings is 922727 which is 10.46% below its average volume of 1030610.
Revenue Growth
Year-on-year quarterly revenue growth grew by 103.1%, now sitting on 935.06M for the twelve trailing months.
2. Ares Capital (ARCC)
26.9% sales growth and 6.51% return on equity
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
Earnings Per Share
As for profitability, Ares Capital has a trailing twelve months EPS of $3.46.
PE Ratio
Ares Capital has a trailing twelve months price to earnings ratio of 5.29. Meaning, the purchaser of the share is investing $5.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.51%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21%, now sitting on 2.1B for the twelve trailing months.
Volume
Today’s last reported volume for Ares Capital is 1580370 which is 55.23% below its average volume of 3530510.
Moving Average
Ares Capital’s worth is below its 50-day moving average of $19.25 and below its 200-day moving average of $19.06.
Yearly Top and Bottom Value
Ares Capital’s stock is valued at $18.31 at 11:22 EST, way below its 52-week high of $22.65 and way higher than its 52-week low of $16.53.
Previous days news about Ares Capital(ARCC)
- According to Zacks on Thursday, 30 March, "We have selected five dividend growth stocks - Barings BDC (BBDC Quick QuoteBBDC – Free Report) , Arbor Realty Trust (ABR Quick QuoteABR – Free Report) , Ares Capital (ARCC Quick QuoteARCC – Free Report) , Hercules Capital (HTGC Quick QuoteHTGC – Free Report) and TriplePoint Venture Growth BDC (TPVG Quick QuoteTPVG – Free Report) - that could be compelling picks amid market volatility.", "Maryland-based Ares Capital is a specialty finance company, which primarily invests in U.S. middle-market companies. "
3. Medpace Holdings (MEDP)
19.5% sales growth and 36.64% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $7.13.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 25.32. Meaning, the purchaser of the share is investing $25.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.64%.
Moving Average
Medpace Holdings’s worth is way below its 50-day moving average of $209.02 and under its 200-day moving average of $184.86.
4. Allegion plc Ordinary Shares (ALLE)
18.7% sales growth and 53.7% return on equity
Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door closers and controls; doors and door systems; electronic security products; electronic, biometric and mobile access control systems; exit devices; locks, locksets, portable locks, and key systems; time, attendance, and workforce productivity systems; and other accessories. The company sells its products and solutions to end-users in commercial, institutional, and residential facilities, including education, healthcare, government, hospitality, commercial office, and single and multi-family residential markets under the CISA, Interflex, LCN, Schlage, SimonsVoss, and Von Duprin brands. It sells its products and solutions through distribution and retail channels, such as specialty distribution, e-commerce, and wholesalers, as well as through various retail channels comprising do-it-yourself home improvement centers, on-line and e-commerce platforms, and small specialty showroom outlets. Allegion plc was incorporated in 2013 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, Allegion plc Ordinary Shares has a trailing twelve months EPS of $5.1.
PE Ratio
Allegion plc Ordinary Shares has a trailing twelve months price to earnings ratio of 19.73. Meaning, the purchaser of the share is investing $19.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.7%.
Yearly Top and Bottom Value
Allegion plc Ordinary Shares’s stock is valued at $100.60 at 11:22 EST, way under its 52-week high of $123.46 and way above its 52-week low of $87.33.
Sales Growth
Allegion plc Ordinary Shares’s sales growth is 17.1% for the present quarter and 18.7% for the next.
5. Synovus Financial Corp. (SNV)
15.5% sales growth and 15.51% return on equity
Synovus Financial Corp. operates as the bank holding company for Synovus Bank that provides commercial and retail banking products and services. It operates through three segments: Community Banking, Wholesale Banking, and Financial Management Services. The company's commercial banking services include treasury management, asset management, capital market, and institutional trust services, as well as commercial, financial, and real estate loans. Its retail banking services comprise accepting customary types of demand and savings deposits accounts; mortgage, installment, and other consumer loans; investment and brokerage services; safe deposit services; automated banking services; automated fund transfers; Internet-based banking services; and bank credit and debit card services. The company also offers various other financial services, including portfolio management for fixed-income securities, investment banking, execution of securities transactions as a broker/dealer, and financial planning services, as well as provides individual investment advice on equity and other securities. As of December 31, 2020, it operated through 289 branches and 389 ATMs in Alabama, Florida, Georgia, South Carolina, and Tennessee. The company was founded in 1888 and is headquartered in Columbus, Georgia.
Earnings Per Share
As for profitability, Synovus Financial Corp. has a trailing twelve months EPS of $3.3.
PE Ratio
Synovus Financial Corp. has a trailing twelve months price to earnings ratio of 9.18. Meaning, the purchaser of the share is investing $9.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.51%.
Yearly Top and Bottom Value
Synovus Financial Corp.’s stock is valued at $30.26 at 11:22 EST, way under its 52-week high of $50.23 and way higher than its 52-week low of $27.08.
Volume
Today’s last reported volume for Synovus Financial Corp. is 1378910 which is 19.19% below its average volume of 1706420.
6. Lattice Semiconductor Corporation (LSCC)
13.6% sales growth and 39.81% return on equity
Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor products in Asia, Europe, and the Americas. The company offers field programmable gate arrays that consist of four product families, including the Certus-NX and ECP, MachXO, iCE40, and CrossLink. It also provides video connectivity application specific standard products. In addition, the company licenses its technology portfolio through standard IP and IP core licensing, patent monetization, and IP services. It sells its products directly to end customers, and indirectly through a network of independent manufacturers' representatives and independent distributors. The company primarily serves original equipment manufacturers in the communications and computing, consumer, and industrial and automotive end markets. Lattice Semiconductor Corporation was incorporated in 1983 and is headquartered in Hillsboro, Oregon.
Earnings Per Share
As for profitability, Lattice Semiconductor Corporation has a trailing twelve months EPS of $1.27.
PE Ratio
Lattice Semiconductor Corporation has a trailing twelve months price to earnings ratio of 70.44. Meaning, the purchaser of the share is investing $70.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.81%.
7. Infosys Limited (INFY)
9.2% sales growth and 32.49% return on equity
Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application development and management, independent validation, product engineering and management, infrastructure management, enterprise application management, and support and integration services. The company's products and platforms include Finacle, a core banking solution; Edge suite of products; Infosys Nia, an artificial intelligence platform; Infosys McCamish – an insurance platform; Wingspan, a customizable learning platform; Stater mortgage servicing platform; Panaya automation suite; and Skava, an e-commerce suite. The company serves clients in the financial services and insurance, life sciences and healthcare, manufacturing, retail, consumer packaged goods and logistics, hi-tech, communications, telecom OEM, media, energy, utilities, resources, services, and other industries. It has collaboration agreements with Rolls-Royce, BP plc, Newmont Corporation, RXR Realty, Majesco Limited, and Centre for Accessibility Australia; and a strategic partnership with The Economist Group Limited to enable and enhance sustainability solutions through a business-to-business model. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Limited in June 2011. Infosys Limited was incorporated in 1981 and is headquartered in Bengaluru, India.
Earnings Per Share
As for profitability, Infosys Limited has a trailing twelve months EPS of $0.61.
PE Ratio
Infosys Limited has a trailing twelve months price to earnings ratio of 28.47. Meaning, the purchaser of the share is investing $28.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.49%.
8. Ulta Beauty (ULTA)
6.3% sales growth and 60.94% return on equity
Ulta Beauty, Inc. operates as a retailer of beauty products in the United States. The company's stores offer cosmetics, fragrances, skincare and haircare products, bath and body products, and salon styling tools; professional hair products; salon services, including hair, skin, makeup, and brow services; and nail services. It also provides its private label products, such as the Ulta Beauty Collection branded cosmetics, skincare, and bath products, as well as Ulta Beauty branded products; and the Ulta Beauty branded gifts. It also distributes its products through its website ulta.com; and mobile applications. The company was formerly known as Ulta Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.
Earnings Per Share
As for profitability, Ulta Beauty has a trailing twelve months EPS of $3.11.
PE Ratio
Ulta Beauty has a trailing twelve months price to earnings ratio of 173.95. Meaning, the purchaser of the share is investing $173.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.94%.
Volume
Today’s last reported volume for Ulta Beauty is 258126 which is 55.75% below its average volume of 583409.
Moving Average
Ulta Beauty’s worth is above its 50-day moving average of $515.28 and way higher than its 200-day moving average of $442.52.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 3.1% and 3.7%, respectively.
Sales Growth
Ulta Beauty’s sales growth is 10.4% for the current quarter and 6.3% for the next.
Previous days news about Ulta Beauty(ULTA)
- According to Zacks on Tuesday, 28 March, "Three stocks - Ulta Beauty (ULTA Quick QuoteULTA – Free Report) , Carnival (CCL Quick QuoteCCL – Free Report) , and Occidental Petroleum (OXY Quick QuoteOXY – Free Report) - have all recently received price target upgrades. ", "And recently, all three stocks above - Ulta Beauty (ULTA Quick QuoteULTA – Free Report) , Carnival (CCL Quick QuoteCCL – Free Report) , and Occidental Petroleum (OXY Quick QuoteOXY – Free Report) - have received price target upgrades."
- According to Zacks on Thursday, 30 March, "Some top-ranked stocks are Build-A-Bear Workshop, Inc. (BBW Quick QuoteBBW – Free Report) , Ulta Beauty (ULTA Quick QuoteULTA – Free Report) and NIKE, Inc. (NKE Quick QuoteNKE – Free Report) .BBW has a trailing four-quarter earnings surprise of 17.4%, on average. "
